nach oben

Erschienen in:

2017 | OriginalPaper | Buchkapitel

3. Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use

verfasst von : F. Herranz, M. P. Morales, I. Rodríguez, J. Ruiz-Cabello

Erschienen in: Magnetic Characterization Techniques for Nanomaterials

Verlag: Springer Berlin Heidelberg

Einloggen

Aktivieren Sie unsere intelligente Suche, um passende Fachinhalte oder Patente zu finden.

search-config

KI-gestützte Suche

Aus

Abstract

Iron oxide nanoparticles are one of the most important materials for magnetic resonance imaging. The possibility of multifunctionalization, lack of toxicity, and variety of compositions make them ideal for many applications. Furthermore, the new generation of nanoparticles for “positive” contrast will increase even more their utility, particularly in the clinic.

Sie haben noch keine Lizenz? Dann Informieren Sie sich jetzt über unsere Produkte:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

über 102.000 Bücher
über 537 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Finance + Banking
Management + Führung
Marketing + Vertrieb
Maschinenbau + Werkstoffe
Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

über 67.000 Bücher
über 390 Zeitschriften

aus folgenden Fachgebieten:

Automobil + Motoren
Bauwesen + Immobilien
Business IT + Informatik
Elektrotechnik + Elektronik
Energie + Nachhaltigkeit
Maschinenbau + Werkstoffe

Jetzt Wissensvorsprung sichern!

Jetzt informieren

Vorheriges Kapitel Magnetic Rotational Spectroscopy for Probing Rheology of Nanoliter Droplets and Thin Films

Nächstes Kapitel Nonlinear Nonequilibrium Simulations of Magnetic Nanoparticles

Merbach A, Helm L, Toth E (2013) The chemistry of contrast agents in medical magnetic resonance imaging. Wiley, HobokenCrossRef

Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L et al (2008) Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108:2064–2110. doi:10.1021/cr068445e CrossRef

Tartaj P, Morales MP, Gonzalez-Carreño T, Veintemillas-Verdaguer S, Serna CJ (2011) The iron oxides strike back: from biomedical applications to energy storage devices and photoelectrochemical water splitting. Adv Mater 23:5243–5249CrossRef

Tartaj P, Morales MP, Veintemillas-verdaguer S, Gonzalez-carreño T, Serna CJ (2006) Synthesis, properties and biomedical applications of magnetic.;16. doi:10.1016/S1567-2719(05)16005-3

Ikeda Y, Nagasaki Y (2011) PEGylation technology in nanomedicine. doi:10.1007/12

Moore A, Weissleder R, Bogdanov A Jr (1997) Uptake of dextran-coated monocrystalline iron oxides in tumor cells and macrophages. J Magn Reson Imag JMRI 7:1140–1145CrossRef

Herranz F, del Morales MP, Roca AG, Desco M, Ruiz-Cabello J (2008) A new method for the rapid synthesis of water stable superparamagnetic nanoparticles. Chem – A Eur J 14:9126–9130. doi:10.1002/chem.200800755 CrossRef

Mejías R, Pérez-yagüe S, Gutiérrez L, Cabrera LI, Spada R, Acedo P et al (2011) Biomaterials dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy. Biomaterials 32:2938–2952. doi:10.1016/j.biomaterials.2011.01.008 CrossRef

Groult H, Ruiz-Cabello J, Lechuga-Vieco AV, Mateo J, Benito M, Bilbao I et al (2014) Phosphatidylcholine-coated iron oxide nanomicelles for in vivo prolonged circulation time with an antibiofouling protein corona. Chem – A Eur J. doi:10.1002/chem.201404221

10.

Estephan ZG, Schlenoff PS, Schlenoff JB (2011) Zwitteration as an alternative to PEGylation. Langmuir 27:6794–6800. doi:10.1021/la200227b CrossRef

11.

Bloch F (1946) Nuclear induction. Phys Rev 70:460–474. doi:10.1103/PhysRev.70.460 CrossRef

12.

Purcell E, Torrey H, Pound R (1946) Resonance absorption by nuclear magnetic moments in a solid. Phys Rev 69:37–38. doi:10.1103/PhysRev.69.37 CrossRef

13.

Torrey H (1956) Bloch equations with diffusion terms. Phys Rev 104:563–565. doi:10.1103/PhysRev.104.563 CrossRef

14.

Vuong QL, Berret J-F, Fresnais J, Gossuin Y, Sandre O (2012) A universal scaling law to predict the efficiency of magnetic nanoparticles as MRI T(2)-contrast agents. Adv Healthc Mater 1:502–512. doi:10.1002/adhm.201200078 CrossRef

15.

Collins T (2007) ImageJ for microscopy. Biotechniques 43:S25–S30. doi:10.2144/000112517 CrossRef

16.

Lim J, Yeap SP, Che HX, Low SC (2013) Characterization of magnetic nanoparticle by dynamic light scattering. Nanoscale Res Lett 8:381. doi:10.1186/1556-276X-8-381 CrossRef

17.

Mejías R, Costo R, Roca AG, Arias CF, Veintemillas-Verdaguer S, González-Carreño T et al (2008) Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery. J Control Release Off J Control Release Soc 130:168–174. doi:10.1016/j.jconrel.2008.05.028 CrossRef

18.

Selim KMK, Ha Y, Kim S, Chang Y, Kim T, Ho G et al (2007) Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. 28:710–716. doi:10.1016/j.biomaterials.2006.09.014

19.

Qu H, Caruntu D, Liu H, O’Connor CJ (2011) Water-dispersible iron oxide magnetic nanoparticles with versatile surface functionalities. Langmuir 27:2271–2278. doi:10.1021/la104471r CrossRef

20.

Shieh D-B, Cheng F-Y, Su C-H, Yeh C-S, Wu M-T, Wu Y-N et al (2005) Aqueous dispersions of magnetite nanoparticles with NH3+ surfaces for magnetic manipulations of biomolecules and MRI contrast agents. Biomaterials 26:7183–7191. doi:10.1016/j.biomaterials.2005.05.020 CrossRef

21.

Kharisov BI, Dias HVR, Kharissova OV, Vázquez A, Peña Y, Gómez I (2014) Solubilization, dispersion and stabilization of magnetic nanoparticles in water and non-aqueous solvents: recent trends. RSC Adv 4:45354–45381. doi:10.1039/C4RA06902A CrossRef

22.

Canfarotta F, Piletsky SA (2014) Engineered magnetic nanoparticles for biomedical applications. Adv Healthc Mater 3:160–175. doi:10.1002/adhm.201300141 CrossRef

23.

Issa B, Obaidat IM, Albiss BA, Haik Y (2013) Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci 14:21266–21305. doi:10.3390/ijms141121266 CrossRef

24.

Tuček P, Tučková M, Fišerová E, Tuček J, Kubáček L (2012) Design of experiment for measurement of Langevin function. Meas Sci Rev 12. doi:10.2478/v10048-012-0019-4

25.

Garcia MA, Fernandez Pinel E, de la Venta J, Quesada A, Bouzas V, Fernández JF et al (2009) Sources of experimental errors in the observation of nanoscale magnetism. J Appl Phys 105:013925. doi:10.1063/1.3060808 CrossRef

26.

Ortega D, Vélez-Fort E, García DA, García R, Litrán R, Barrera-Solano C et al (2010) Size and surface effects in the magnetic properties of maghemite and magnetite coated nanoparticles. Philos Trans A Math Phys Eng Sci 368:4407–4418. doi:10.1098/rsta.2010.0172 CrossRef

27.

Costo R, Bello V, Robic C, Port M, Marco JF, Puerto Morales M et al (2012) Ultrasmall iron oxide nanoparticles for biomedical applications: improving the colloidal and magnetic properties. Langmuir 28:178–185. doi:10.1021/la203428z CrossRef

28.

Garcia-Palacios JL (2009) On the statics and dynamics of magneto-anisotropic nanoparticles. Advances in Chemical Physics, vol. 112 (2000) 1–210

29.

Egli R (2009) Magnetic susceptibility measurements as a function of temperature and frequency I: inversion theory. Geophys J Int 177:395–420. doi:10.1111/j.1365-246X.2009.04081.x CrossRef

30.

Hansen MF, Jönsson PE, Nordblad P, Svedlindh P (2002) Critical dynamics of an interacting magnetic nanoparticle system. J Phys Condens Matter 14:4901–4914. doi:10.1088/0953-8984/14/19/314 CrossRef

31.

Raikher YL, Stepanov VI (2008) Magnetic relaxation in a suspension of antiferromagnetic nanoparticles. J Exp Theor Phys 107:435–444. doi:10.1134/S1063776108090112 CrossRef

32.

Gutiérrez L, Morales MP, Lázaro FJ (2014) Prospects for magnetic nanoparticles in systemic administration: synthesis and quantitative detection. Phys Chem Chem Phys 16:4456–4464. doi:10.1039/c3cp54763a CrossRef

33.

Wang G, Inturi S, Serkova NJ, Merkulov S, McCrae K, Russek SE et al (2014) High-relaxivity superparamagnetic iron oxide nanoworms with decreased immune recognition and long-circulating properties. ACS Nano 8:12437–12449. doi:10.1021/nn505126b CrossRef

34.

Casals E, Pfaller T, Duschl A, Oostingh GJ, Puntes V (2010) Time evolution of the nanoparticle protein corona. ACS Nano 4:3623–3632. doi:10.1021/nn901372t CrossRef

35.

Barrán-Berdón AL, Pozzi D, Caracciolo G, Capriotti AL, Caruso G, Cavaliere C et al (2013) Time evolution of nanoparticle–protein corona in human plasma: relevance for targeted drug delivery. Langmuir 29:6485–6494. doi:10.1021/la401192x CrossRef

36.

Tenzer S, Docter D, Kuharev J, Musyanovych A, Fetz V, Hecht R et al (2013) Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol 8:772–781. doi:10.1038/nnano.2013.181 CrossRef

37.

Herranz F, Morales MP, Roca AG, Vilar R, Ruiz-Cabello J (2008) A new method for the aqueous functionalization of superparamagnetic Fe₂O₃ nanoparticles. Contrast Media Mol Imaging 3:215–222CrossRef

38.

Lattuada M, Hatton TA (2007) Functionalization of monodisperse magnetic nanoparticles. Langmuir ACS J Surf Colloids 23:2158–2168. doi:10.1021/la062092x CrossRef

39.

Gage SH, Stein BD, Nikoshvili LZ, Matveeva VG, Sulman MG, Sulman EM et al (2013) Functionalization of monodisperse iron oxide NPs and their properties as magnetically recoverable catalysts. Langmuir ACS J Surf Colloids 29:466–473. doi:10.1021/la304410z CrossRef

40.

Quarta A, Curcio A, Kakwere H, Pellegrino T (2012) Polymer coated inorganic nanoparticles: tailoring the nanocrystal surface for designing nanoprobes with biological implications. Nanoscale 4. doi:10.1039/c2nr30271c

41.

Maleki H, Simchi A, Imani M, Costa BFO (2012) Size-controlled synthesis of superparamagnetic iron oxide nanoparticles and their surface coating by gold for biomedical applications. J Magn Magn Mater 324:3997–4005. doi:10.1016/j.jmmm.2012.06.045 CrossRef

42.

Herranz F, Schmidt-Weber CB, Shamji MH, Narkus A, Ruiz-Cabello J, Vilar R (2012) Superparamagnetic iron oxide nanoparticles conjugated to a grass pollen allergen and an optical probe. Contrast Media Mol Imaging 7:435–439. doi:10.1002/cmmi.1466 CrossRef

43.

Rodríguez I, Pérez-Rial S, González-Jimenez J, Pérez-Sánchez J, Herranz F, Beckmann N et al (2008) Magnetic resonance methods and applications in pharmaceutical research. J Pharm Sci 97:3637–3665. doi:10.1002/jps.21281 CrossRef

44.

Roca AG, Veintemillas-Verdaguer S, Port M, Robic C, Serna CJ, Morales MP (2009) Effect of nanoparticle and aggregate size on the relaxometric properties of MR contrast agents based on high quality magnetite nanoparticles. J Phys Chem B 113:7033–7039. doi:10.1021/jp807820s CrossRef

45.

Mejías R, Pérez-Yagüe S, Roca AG, Pérez N, Villanueva A, Cañete M et al (2010) Liver and brain imaging through dimercaptosuccinic acid-coated iron oxide nanoparticles. Nanomedicine (Lond) 5:397–408. doi:10.2217/nnm.10.15 CrossRef

46.

Zhou H-P, Xu C-H, Sun W, Yan C-H (2009) Clean and flexible modification strategy for carboxyl/aldehyde-functionalized upconversion nanoparticles and their optical applications. Adv Funct Mater 19:3892–3900. doi:10.1002/adfm.200901458 CrossRef

47.

Xia T, Wang J, Wu C, Meng F, Shi Z, Lian J et al (2012) Novel complex-coprecipitation route to form high quality triethanolamine-coated Fe₃O₄ nanocrystals: their high saturation magnetizations and excellent water treatment properties. CrystEngComm 14:5741. doi:10.1039/c2ce25813g CrossRef

48.

Korpany KV, Habib F, Murugesu M, Blum AS (2013) Stable water-soluble iron oxide nanoparticles using Tiron. Mater Chem Phys 138:29–37. doi:10.1016/j.matchemphys.2012.10.015 CrossRef

49.

Liang G, Xiao L, Chen H, Liu Q, Zhang S, Li F et al (2013) Label-free, nucleotide-mediated dispersion of magnetic nanoparticles for “non-sandwich type” MRI-based quantification of enzyme. Biosens Bioelectron 41:78–83. doi:10.1016/j.bios.2012.07.025 CrossRef

50.

Hamed A, Fitzgerald AG, Wang LY, Gueorguieva M, Malik R, Melzer A (2013) Characterisation of Mn0 · 7Zn0 · 3Fe₂O₄ nanoparticles prepared by two stage annealing. Mater Technol 28:339–346. doi:10.1179/1753555713Y.0000000066 CrossRef

51.

Towards MRI T2 contrast agents of increased efficiency. (n.d.) J Magn Magn Mater. doi:10.1010/j.jmmm.2014.10.086

52.

Ruiz-Cabello J, Morales MP, Salinas B, Herranz F (2012) Olefin metathesis for the functionalization of superparamagnetic nanoparticles. Bioinspired, Biomim Nanobiomater 1:166–172. doi:10.1680/bbn.12.00001 CrossRef

53.

Lin YA, Chalker JM, Davis BG (2009) Olefin metathesis for site-selective protein modification. 959–969. doi:10.1002/cbic.200900002

54.

Li M, Song Y, Cho N, Chang JM, Koo HR, Yi A et al (2011) An HR-MAS MR metabolomics study on breast tissues obtained with core needle biopsy. PLoS One 6, e25563. doi:10.1371/journal.pone.0025563 CrossRef

55.

André M, Dumez J-N, Rezig L, Shintu L, Piotto M, Caldarelli S (2014) Complete protocol for slow-spinning high-resolution magic-angle spinning NMR analysis of fragile tissues. Anal Chem 86:10749–10754. doi:10.1021/ac502792u CrossRef

56.

Das M, Bandyopadhyay D, Mishra D, Datir S, Dhak P, Jain S et al (2011) “Clickable”, trifunctional magnetite nanoparticles and their chemoselective biofunctionalization. Bioconjug Chem 22:1181–1193. doi:10.1021/bc2000484 CrossRef

57.

Polito L, Colombo M, Monti D, Melato S, Caneva E, Prosperi D (2008) Resolving the structure of ligands bound to the surface of superparamagnetic iron oxide nanoparticles by high-resolution magic-angle spinning NMR spectroscopy. J Am Chem Soc 130:12712–12724. doi:10.1021/ja802479n CrossRef

58.

Groult H, Ruiz-Cabello J, Pellico J, Lechuga-Vieco AV, Bhavesh R, Zamai M et al (2014) Parallel multifunctionalization of nanoparticles: a one-step modular approach for in vivo imaging. Bioconjug Chem(in press). doi:10.1021/bc500536y

59.

Chen H, Liu S, Li Y, Deng C, Zhang X, Yang P (2011) Development of oleic acid-functionalized magnetite nanoparticles as hydrophobic probes for concentrating peptides with MALDI-TOF-MS analysis. Proteomics 11:890–897. doi:10.1002/pmic.201000509 CrossRef

60.

Kim BH, Shin K, Kwon SG, Jang Y, Lee H-S, Lee H et al (2013) Sizing by weighing: characterizing sizes of ultrasmall-sized iron oxide nanocrystals using MALDI-TOF mass spectrometry. J Am Chem Soc 135:2407–2410. doi:10.1021/ja310030c CrossRef

61.

Chung J, Yu J-S, Kim DJ, Chung J-J, Kim JH, Kim KW (2011) Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Magn Reson Imaging 29:1235–1243. doi:10.1016/j.mri.2011.07.025 CrossRef

62.

Zhao S, Wang Y, Gao C, Zhang J, Bao H, Wang Z et al (2014) Superparamagnetic iron oxide magnetic nanomaterial-labeled bone marrow mesenchymal stem cells for rat liver repair after hepatectomy. J Surg Res 191:290–301. doi:10.1016/j.jss.2014.03.064 CrossRef

63.

Teerasamit W, Saiviroonporn P, Pongpaibul A, Korpraphong P (2014) Benefit of double contrast MRI in diagnosis of hepatocellular carcinoma in patients with chronic liver diseases. J Med Assoc Thai 97:540–547

64.

Zhao J, Vykoukal J, Abdelsalam M, Recio-Boiles A, Huang Q, Qiao Y et al (2014) Stem cell-mediated delivery of SPIO-loaded gold nanoparticles for the theranosis of liver injury and hepatocellular carcinoma. Nanotechnology 25:405101. doi:10.1088/0957-4484/25/40/405101 CrossRef

65.

Groult H, Ruiz-Cabello J, Lechuga-Vieco AV, Mateo J, Benito M, Bilbao I, Martínez-Alcázar MP, Lopez JA, Vázquez J, Herranz FF (2014) Phosphatidylcholine-Coated Iron Oxide Nanomicelles for In Vivo Prolonged Circulation Time with an Antibiofouling Protein Corona. Chem - A Eur J 20:16662–16671CrossRef

66.

Qi H, Li Z, Du K, Mu K, Zhou Q, Liang S et al (2014) Transferrin-targeted magnetic/fluorescence micelles as a specific bi-functional nanoprobe for imaging liver tumor. Nanoscale Res Lett 9:595. doi:10.1186/1556-276X-9-595 CrossRef

67.

Yang R-M, Fu C-P, Li N-N, Wang L, Xu X-D, Yang D-Y et al (2014) Glycosaminoglycan-targeted iron oxide nanoparticles for magnetic resonance imaging of liver carcinoma. Mater Sci Eng C Mater Biol Appl 45:556–563. doi:10.1016/j.msec.2014.09.038 CrossRef

68.

Yu MK, Kim D, Lee I-H, So J-S, Jeong YY, Jon S (2011) Image-guided prostate cancer therapy using aptamer-functionalized thermally cross-linked superparamagnetic iron oxide nanoparticles. Small 7:2241–2249. doi:10.1002/smll.201100472 CrossRef

69.

Li Q, Qi H, Zhou H-X, Deng C-Y, Zhu H, Li J-F et al (2011) Detection of micrometastases in peripheral blood of non-small cell lung cancer with a refined immunomagnetic nanoparticle enrichment assay. Int J Nanomedicine 6:2175–2181. doi:10.2147/IJN.S24731 CrossRef

70.

Corem-Salkmon E, Perlstein B, Margel S (2012) Design of near-infrared fluorescent bioactive conjugated functional iron oxide nanoparticles for optical detection of colon cancer. Int J Nanomedicine 7:5517–5527. doi:10.2147/IJN.S33710

71.

Shao H, Chung J, Balaj L, Charest A, Bigner DD, Carter BS et al (2012) Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy. Nat Med 18:1835–1840. doi:10.1038/nm.2994 CrossRef

72.

Niu C, Wang Z, Lu G, Krupka TM, Sun Y, You Y et al (2013) Doxorubicin loaded superparamagnetic PLGA-iron oxide multifunctional microbubbles for dual-mode US/MR imaging and therapy of metastasis in lymph nodes. Biomaterials 34:2307–2317. doi:10.1016/j.biomaterials.2012.12.003 CrossRef

73.

Shahbazi-Gahrouei D, Abdolahi M (2013) Superparamagnetic iron oxide-C595: potential MR imaging contrast agents for ovarian cancer detection. J Med Phys 38:198–204. doi:10.4103/0971-6203.121198 CrossRef

74.

Lee JY, Kim J-H, Bae KH, Oh MH, Kim Y, Kim JS et al (2014) Low-density lipoprotein-mimicking nanoparticles for tumor-targeted theranostic applications. Small. doi:10.1002/smll.201303277

75.

Tse BW-C, Cowin GJ, Soekmadji C, Jovanovic L, Vasireddy RS, Ling M-T et al (2014) PSMA-targeting iron oxide magnetic nanoparticles enhance MRI of preclinical prostate cancer. Nanomedicine (Lond):1–12. doi:10.2217/nnm.14.122

76.

77.

Wang L, Zhong X, Qian W, Huang J, Cao Z, Yu Q, Lipowska, M, Lin R, Wang A, Yang L, Mao H (2014) Ultrashort Echo Time (UTE) imaging of receptor targeted magnetic iron oxide nanoparticles in mouse tumor models. J Magn Reson Imaging 40:1071–1081CrossRef

78.

Briley-Saebo KC, Cho YS, Shaw PX, Ryu SK, Mani V, Dickson S et al (2011) Targeted iron oxide particles for in vivo magnetic resonance detection of atherosclerotic lesions with antibodies directed to oxidation-specific epitopes. J Am Coll Cardiol 57:337–347. doi:10.1016/j.jacc.2010.09.023 CrossRef

79.

Wagner S, Schnorr J, Ludwig A, Stangl V, Ebert M, Hamm B et al (2013) Contrast-enhanced MR imaging of atherosclerosis using citrate-coated superparamagnetic iron oxide nanoparticles: calcifying microvesicles as imaging target for plaque characterization. Int J Nanomedicine 8:767–779. doi:10.2147/IJN.S38702

80.

Wen S, Liu D-F, Cui Y, Harris SS, Chen Y, Li KC et al (2013) In vivo MRI detection of carotid atherosclerotic lesions and kidney inflammation in ApoE-deficient mice by using LOX-1 targeted iron nanoparticles. Nanomed Nanotechnol, Biol Med. doi:10.1016/j.nano.2013.09.009

81.

You DG, Saravanakumar G, Son S, Han HS, Heo R, Kim K et al (2014) Dextran sulfate-coated superparamagnetic iron oxide nanoparticles as a contrast agent for atherosclerosis imaging. Carbohydr Polym 101:1225–1233. doi:10.1016/j.carbpol.2013.10.068 CrossRef

82.

Pellico J, Lechuga-Vieco AV, Benito M, García-Segura JM, Fuster V, Ruiz-Cabello J et al (2014) Microwave-driven synthesis of bisphosphonate nanoparticles allows in vivo visualisation of atherosclerotic plaque. RSC Adv 5:1661–1665. doi:10.1039/C4RA13824D CrossRef

83.

Le Bihan D, Joly O, Aso T, Uhrig L, Poupon C, Tani N et al (2012) Brain tissue water comes in two pools: evidence from diffusion and R2’ measurements with USPIOs in non human primates. Neuroimage 62:9–16. doi:10.1016/j.neuroimage.2012.05.011 CrossRef

84.

Thomsen LB, Linemann T, Pondman KM, Lichota J, Kim KS, Pieters RJ et al (2013) Uptake and transport of superparamagnetic iron oxide nanoparticles through human brain capillary endothelial cells. ACS Chem Neurosci 4:1352–1360. doi:10.1021/cn400093z CrossRef

85.

Mori Y, Chen T, Fujisawa T, Kobashi S, Ohno K, Yoshida S, Tago Y, Komai Y, Hata Y, Yoshioka Y (2014) From Cartoon to Real Time MRI: In Vivo Monitoring of Phagocyte Migration in Mouse Brain. Sci Rep 4:6997CrossRef

86.

Gauberti M, Montagne A, Quenault A, Vivien D (2014) Molecular magnetic resonance imaging of brain-immune interactions. Front Cell Neurosci 8:389. doi:10.3389/fncel.2014.00389 CrossRef

87.

Sart S, Bejarano FC, Baird MA, Yan Y, Rosenberg JT, Ma T et al (2015) Intracellular labeling of mouse embryonic stem cell-derived neural progenitor aggregates with micron-sized particles of iron oxide. Cytotherapy 17:98–111. doi:10.1016/j.jcyt.2014.09.008 CrossRef

88.

Choi SH, Moon WK (2010) Contrast-enhanced MR imaging of lymph nodes in cancer patients. Korean J Radiol 11:383–394. doi:10.3348/kjr.2010.11.4.383 CrossRef

89.

Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ (1990) Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 175:494–498. doi:10.1148/radiology.175.2.2326475 CrossRef

90.

Moghimi S, Bonnemain B (1999) Subcutaneous and intravenous delivery of diagnostic agents to the lymphatic system: applications in lymphoscintigraphy and indirect lymphography. Adv Drug Deliv Rev 37:295–312CrossRef

91.

Stets C, Brandt S, Wallis F, Buchmann J, Gilbert FJ, Heywang-Köbrunner SH (2002) Axillary lymph node metastases: a statistical analysis of various parameters in MRI with USPIO. J Magn Reson Imaging 16:60–68. doi:10.1002/jmri.10134 CrossRef

92.

Pultrum BB, van der Jagt EJ, van Westreenen HL, van Dullemen HM, Kappert P, Groen H et al (2009) Detection of lymph node metastases with ultrasmall superparamagnetic iron oxide (USPIO)-enhanced magnetic resonance imaging in oesophageal cancer: a feasibility study. Cancer Imaging 9:19–28. doi:10.1102/1470-7330.2009.0004 CrossRef

93.

Anzai Y, Prince MR (n.d.) Iron oxide-enhanced MR lymphography: the evaluation of cervical lymph node metastases in head and neck cancer. J Magn Reson Imaging 7:75–81

94.

Tokuhara T, Tanigawa N, Matsuki M, Nomura E, Mabuchi H, Lee S-W et al (2008) Evaluation of lymph node metastases in gastric cancer using magnetic resonance imaging with ultrasmall superparamagnetic iron oxide (USPIO): diagnostic performance in post-contrast images using new diagnostic criteria. Gastric Cancer 11:194–200. doi:10.1007/s10120-008-0480-9 CrossRef

95.

Yoo R-E, Choi SH, Cho HR, Jeon B-S, Kwon E, Kim E-G et al (2014) Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands. PLoS One 9, e107583. doi:10.1371/journal.pone.0107583 CrossRef

96.

Mack MG, Balzer JO, Straub R, Eichler K, Vogl TJ (2002) Superparamagnetic iron oxide-enhanced MR imaging of head and neck lymph nodes. Radiology 222:239–244. doi:10.1148/radiol.2221010225 CrossRef

97.

McCauley TR, Rifkin MD, Ledet CA (2002) Pelvic lymph node visualization with MR imaging using local administration of ultra-small superparamagnetic iron oxide contrast. J Magn Reson Imaging 15:492–497CrossRef

98.

Hudgins PA, Anzai Y, Morris MR, Lucas MA (2002) Ferumoxtran-10, a superparamagnetic iron oxide as a magnetic resonance enhancement agent for imaging lymph nodes: a phase 2 dose study. AJNR Am J Neuroradiol 23:649–656

99.

Sigal R, Vogl T, Casselman J, Moulin G, Veillon F, Hermans R et al (2002) Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) – results of a phase-III multicenter clinical trial. Eur Radiol 12:1104–1113. doi:10.1007/s003300101130 CrossRef

100.

Rockall AG, Sohaib SA, Harisinghani MG, Babar SA, Singh N, Jeyarajah AR et al (2005) Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 23:2813–2821. doi:10.1200/JCO.2005.07.166 CrossRef

101.

Harisinghani MG, Saksena MA, Hahn PF, King B, Kim J, Torabi MT et al (2006) Ferumoxtran-10-enhanced MR lymphangiography: does contrast-enhanced imaging alone suffice for accurate lymph node characterization? AJR Am J Roentgenol 186:144–148. doi:10.2214/AJR.04.1287 CrossRef

102.

Stadnik TW, Everaert H, Makkat S, Sacré R, Lamote J, Bourgain C (2006) Breast imaging. Preoperative breast cancer staging: comparison of USPIO-enhanced MR imaging and 18F-fluorodeoxyglucose (FDC) positron emission tomography (PET) imaging for axillary lymph node staging–initial findings. Eur Radiol 16:2153–2160. doi:10.1007/s00330-006-0276-4 CrossRef

103.

Harisinghani M, Ross RW, Guimaraes AR, Weissleder R (2007) Utility of a new bolus-injectable nanoparticle for clinical cancer staging. Neoplasia 9:1160–1165CrossRef

104.

Guimaraes AR, Tabatabei S, Dahl D, McDougal WS, Weissleder R, Harisinghani MG (2008) Pilot study evaluating use of lymphotrophic nanoparticle-enhanced magnetic resonance imaging for assessing lymph nodes in renal cell cancer. Urology 71:708–712. doi:10.1016/j.urology.2007.11.096 CrossRef

105.

Heesakkers RAM, Hövels AM, Jager GJ, van den Bosch HCM, Witjes JA, Raat HPJ et al (2008) MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study. Lancet Oncol 9:850–856. doi:10.1016/S1470-2045(08)70203-1 CrossRef

106.

Ross RW, Zietman AL, Xie W, Coen JJ, Dahl DM, Shipley WU et al (n.d.) Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy. Clin Imaging 33:301–5. doi:10.1016/j.clinimag.2009.01.013

107.

Kimura K, Tanigawa N, Matsuki M, Nohara T, Iwamoto M, Sumiyoshi K et al (2010) High-resolution MR lymphography using ultrasmall superparamagnetic iron oxide (USPIO) in the evaluation of axillary lymph nodes in patients with early stage breast cancer: preliminary results. Breast Cancer 17:241–246. doi:10.1007/s12282-009-0143-7 CrossRef

108.

Johnson L, Pinder SE, Douek M (2013) Deposition of superparamagnetic iron-oxide nanoparticles in axillary sentinel lymph nodes following subcutaneous injection. Histopathology 62:481–486. doi:10.1111/his.12019 CrossRef

109.

Thill M, Kurylcio A, Welter R, van Haasteren V, Grosse B, Berclaz G et al (2014) The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs. radioisotope. Breast 23:175–179. doi:10.1016/j.breast.2014.01.004 CrossRef

110.

Birkhäuser FD, Studer UE, Froehlich JM, Triantafyllou M, Bains LJ, Petralia G et al (2013) Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging facilitates detection of metastases in normal-sized pelvic lymph nodes of patients with bladder and prostate cancer. Eur Urol 64:953–960. doi:10.1016/j.eururo.2013.07.032 CrossRef

111.

Michel SCA, Keller TM, Fröhlich JM, Fink D, Caduff R, Seifert B et al (2002) Preoperative breast cancer staging: MR imaging of the axilla with ultrasmall superparamagnetic iron oxide enhancement. Radiology 225:527–536. doi:10.1148/radiol.2252011605 CrossRef

112.

Anzai Y, Piccoli CW, Outwater EK, Stanford W, Bluemke DA, Nurenberg P et al (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228:777–788. doi:10.1148/radiol.2283020872 CrossRef

113.

Heesakkers RAM, Fütterer JJ, Hövels AM, van den Bosch HCM, Scheenen TWJ, Hoogeveen YL et al (2006) Prostate cancer evaluated with ferumoxtran-10-enhanced T2*-weighted MR Imaging at 1.5 and 3.0 T: early experience. Radiology 239:481–487. doi:10.1148/radiol.2392050411 CrossRef

114.

Saksena M, Harisinghani M, Hahn P, Kim J, Saokar A, King B et al (2006) Comparison of lymphotropic nanoparticle-enhanced MRI sequences in patients with various primary cancers. AJR Am J Roentgenol 187:W582–W588. doi:10.2214/AJR.05.0873 CrossRef

115.

Engelen SME, Beets-Tan RGH, Lahaye MJ, Lammering G, Jansen RLH, van Dam RM et al (2010) MRI after chemoradiotherapy of rectal cancer: a useful tool to select patients for local excision. Dis Colon Rectum 53:979–986. doi:10.1007/DCR.0b013e3181dc64dc CrossRef

116.

Rubio IT, Diaz-Botero S, Esgueva A, Rodriguez R, Cortadellas T, Cordoba O et al (2014) The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer. Eur J Surg Oncol. doi:10.1016/j.ejso.2014.11.006

117.

Briley-Saebo KC, Mulder WJM, Mani V, Hyafil F, Amirbekian V, Aguinaldo JGS et al (2007) Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 26:460–479. doi:10.1002/jmri.20989 CrossRef

118.

McAteer MA, Akhtar AM, von Zur Muhlen C, Choudhury RP (2010) An approach to molecular imaging of atherosclerosis, thrombosis, and vascular inflammation using microparticles of iron oxide. Atherosclerosis 209:18–27. doi:10.1016/j.atherosclerosis.2009.10.009 CrossRef

119.

Ross R (1999) Atherosclerosis–an inflammatory disease. N Engl J Med 340:115–126. doi:10.1056/NEJM199901143400207 CrossRef

120.

Sanz J, Fayad ZA (2008) Imaging of atherosclerotic cardiovascular disease. Nature 451:953–957. doi:10.1038/nature06803 CrossRef

121.

Wildgruber M (2013) Molecular imaging of inflammation in atherosclerosis. Theranostics 3:865–884. doi:10.7150/thno.5771 CrossRef

122.

Corti R, Fuster V (2011) Imaging of atherosclerosis: magnetic resonance imaging. Eur Heart J 32:1709–1719b. doi:10.1093/eurheartj/ehr068 CrossRef

123.

Sanz J, Moreno PR, Fuster V (2012) The year in atherothrombosis. J Am Coll Cardiol 60:932–942. doi:10.1016/j.jacc.2012.04.045 CrossRef

124.

Otsuka F, Fuster V, Narula J, Virmani R (2012) Omnipresent atherosclerotic disease: time to depart from analysis of individual vascular beds. Mt Sinai J Med 79:641–653. doi:10.1002/msj.21353 CrossRef

125.

Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS et al (2012) Myocardial infarction accelerates atherosclerosis. Nature 487:325–329. doi:10.1038/nature11260 CrossRef

126.

Hermann S, Starsichova A, Waschkau B, Kuhlmann M, Wenning C, Schober O et al (2012) Non-FDG imaging of atherosclerosis: Will imaging of MMPs assess plaque vulnerability? J Nucl Cardiol 19:609–617. doi:10.1007/s12350-012-9553-6 CrossRef

127.

Schmitz SA, Coupland SE, Gust R, Winterhalter S, Wagner S, Kresse M et al (2000) Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits. Invest Radiol 35:460–471CrossRef

128.

Schmitz SA, Taupitz M, Wagner S, Wolf KJ, Beyersdorff D, Hamm B (2001) Magnetic resonance imaging of atherosclerotic plaques using superparamagnetic iron oxide particles. J Magn Reson Imaging JMRI 14:355–361CrossRef

129.

Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF (2001) Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits. Circulation 103:415–422CrossRef

130.

Schmitz SA, Taupitz M, Wagner S, Coupland SE, Gust R, Nikolova A et al (2002) Iron-oxide-enhanced magnetic resonance imaging of atherosclerotic plaques: postmortem analysis of accuracy, inter-observer agreement, and pitfalls. Invest Radiol 37:405–411CrossRef

131.

Kooi ME, Cappendijk VC, Cleutjens KBJM, Kessels AGH, Kitslaar PJEHM, Borgers M et al (2003) Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation 107:2453–2458. doi:10.1161/01.CIR.0000068315.98705.CC CrossRef

132.

Schmitz SA, Winterhalter S, Schiffler S, Gust R, Wagner S, Kresse M et al (2001) USPIO-enhanced direct MR imaging of thrombus: preclinical evaluation in rabbits. Radiology 221:237–243. doi:10.1148/radiol.2211001632 CrossRef

133.

Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL (2010) Imaging atherosclerosis and vulnerable plaque. J Nucl Med 51:51S–65S. doi:10.2967/jnumed.109.068163 CrossRef

134.

Sosnovik DE, Nahrendorf M, Weissleder R (2008) Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications. Basic Res Cardiol 103:122–130. doi:10.1007/s00395-008-0710-7 CrossRef

135.

Tang TY, Muller KH, Graves MJ, Li ZY, Walsh SR, Young V et al (2009) Iron oxide particles for atheroma imaging. Arterioscler Thromb Vasc Biol 29:1001–1008. doi:10.1161/ATVBAHA.108.165514 CrossRef

136.

Satomi T, Ogawa M, Mori I, Ishino S, Kubo K, Magata Y et al (2013) Comparison of contrast agents for atherosclerosis imaging using cultured macrophages: FDG versus ultrasmall superparamagnetic iron oxide. J Nucl Med 54:999–1004. doi:10.2967/jnumed.112.110551 CrossRef

137.

Segers FME, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W et al (2013) Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions. Arterioscler Thromb Vasc Biol 33:1812–1819. doi:10.1161/ATVBAHA.112.300707 CrossRef

138.

Kelly KA (2005) Detection of vascular adhesion molecule-1 expression using a novel multimodal nanoparticle. Circ Res 96:327–336. doi:10.1161/01.RES.0000155722.17881.dd CrossRef

139.

Nahrendorf M, Jaffer FA, Kelly KA, Sosnovik DE, Aikawa E, Libby P et al (2006) Noninvasive vascular cell adhesion molecule-1 imaging identifies inflammatory activation of cells in atherosclerosis. Circulation 114:1504–1511. doi:10.1161/CIRCULATIONAHA.106.646380 CrossRef

140.

Woollard KJ, Chin-Dusting J (2007) Therapeutic targeting of p-selectin in atherosclerosis. Inflamm Allergy Drug Targets 6:69–74CrossRef

141.

Jacobin-Valat M-J, Deramchia K, Mornet S, Hagemeyer CE, Bonetto S, Robert R et al (2011) MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed 24:413–424. doi:10.1002/nbm.1606

142.

Smith BR, Heverhagen J, Knopp M, Schmalbrock P, Shapiro J, Shiomi M et al (2007) Localization to atherosclerotic plaque and biodistribution of biochemically derivatized superparamagnetic iron oxide nanoparticles (SPIONs) contrast particles for magnetic resonance imaging (MRI). Biomed Microdevices 9:719–727. doi:10.1007/s10544-007-9081-3 CrossRef

143.

Pellico J, Lechuga-Vieco AV, Benito M, García-Segura JM, Fuster V, Ruiz-Cabello J et al (2015) Microwave-driven synthesis of bisphosphonate nanoparticles allows in vivo visualisation of atherosclerotic plaque. RSC Adv 5:1661–1665. doi:10.1039/C4RA13824D CrossRef

144.

Ahlström KH, Johansson LO, Rodenburg JB, Ragnarsson AS, Akeson P, Börseth A (1999) Pulmonary MR angiography with ultrasmall superparamagnetic iron oxide particles as a blood pool agent and a navigator echo for respiratory gating: pilot study. Radiology 211:865–869. doi:10.1148/radiology.211.3.r99jn10865 CrossRef

145.

Sigovan M, Boussel L, Sulaiman A, Sappey-Marinier D, Alsaid H, Desbleds-Mansard C et al (2009) Rapid-clearance iron nanoparticles for inflammation imaging of atherosclerotic plaque: initial experience in animal model. Radiology 252:401–409. doi:10.1148/radiol.2522081484 CrossRef

146.

Schnorr J, Taupitz M, Schellenberger EA, Warmuth C, Fahlenkamp UL, Wagner S et al (2012) Cardiac magnetic resonance angiography using blood-pool contrast agents: comparison of citrate-coated very small superparamagnetic iron oxide particles with gadofosveset trisodium in pigs. Rofo 184:105–112. doi:10.1055/s-0031-1281982 CrossRef

147.

Wagner M, Wagner S, Schnorr J, Schellenberger E, Kivelitz D, Krug L et al (2011) Coronary MR angiography using citrate-coated very small superparamagnetic iron oxide particles as blood-pool contrast agent: initial experience in humans. J Magn Reson Imaging 34:816–823. doi:10.1002/jmri.22683 CrossRef

148.

Tanimoto A, Yuasa Y, Hiramatsu K (n.d.) Enhancement of phase-contrast MR angiography with superparamagnetic iron oxide. J Magn Reson Imaging;8:446–450

149.

Schmitz SA, Albrecht T, Wolf KJ (1999) MR angiography with superparamagnetic iron oxide: feasibility study. Radiology 213:603–607. doi:10.1148/radiology.213.2.r99oc24603 CrossRef

150.

Kim BH, Lee N, Kim H, An K, Park YI, Choi Y et al (2011) Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T ₁ magnetic resonance imaging contrast agents. J Am Chem Soc 133:12624–12631. doi:10.1021/ja203340u CrossRef

Titel: Iron Oxide Nanoparticle-Based MRI Contrast Agents: Characterization and In Vivo Use
verfasst von: F. Herranz
M. P. Morales
I. Rodríguez
J. Ruiz-Cabello
Verlag: Springer Berlin Heidelberg
Buch: Magnetic Characterization Techniques for Nanomaterials
Print ISBN: 978-3-662-52779-5

Electronic ISBN: 978-3-662-52780-1

Copyright-Jahr: 2017
DOI: https://doi.org/10.1007/978-3-662-52780-1_3

Premium Partner

Marktübersichten

Die im Laufe eines Jahres in der „adhäsion“ veröffentlichten Marktübersichten helfen Anwendern verschiedenster Branchen, sich einen gezielten Überblick über Lieferantenangebote zu verschaffen.

Zur Marktübersicht